Latest News and Blogs

New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations

Congenica CEO David Atkins PhD is joined by Chairman Andy Richards OBE in announcing the company's Series C fundraise.

We spoke to a number of industry leaders to discuss their thoughts on the culture changes needed to mainstream genomics.

We spoke to a number of industry leaders to find out their thoughts on the importance of improving the efficiency of genetic analysis.

We spoke to a number of industry leaders to discuss their thoughts on the benefits and challenges of mainstreaming genomics and precision medicine

Congenica's response to the UK Government's national genomic healthcare strategy, setting out its vision to extend the UK’s leadership in genomics

Supporting Rare Disease Clinical Genomics: The future of genotype phenotype data standards & sharing for analysis to improve medical outcomes

Poster at Rady's Children's Institute Frontiers in Paediatric Medicine Conference discusses the impact of the Deciphering Developmental Disorders study.

Congenica's new module accelerates research into the relationship between an individual’s genomic variation & COVID-19 susceptibility & clinical outcomes.

The future of genomic medicine: can it fulfil its promises?

Dr Charles Steward discusses the role of genomic medicine in investigating rare disease and his own family’s experiences.

Using appropriate reference data sources helps to improve diagnostic yield and can support faster interpretation of genomic data.